Current Assets Endring Dato
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Arrowhead Research USD 237.9M 181.62M 2023-12
Avrobio USD 109.17M 19.67M 2023-09
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Bluebird Bio USD 247.08M 40.9M 2023-09
Incyte USD 4.65B 242.74M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Moderna USD 10.32B 474M 2023-12
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
PTC Therapeutics USD 1.22B 678.27M 2023-12
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Takeda JPY 2.46T 9.95B 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09
Xencor USD 623.16M 51.98M 2023-12



Alnylam Pharmaceuticals Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.